Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Remain Bullish on Vertex with Price Target Increases

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

On March 2, 2024, JMP Securities analyst Joe Goodwin reiterated a Market Outperform rating on Vertex (NASDAQ: VERX) and increased the price target to $42. This adjustment comes after JMP Securities raised the price target on Vertex to $42.00 from $31.00.

Financial groups like Jefferies Financial Group and Citigroup have also revised their price targets on Vertex, reflecting different perspectives on the company’s performance. Overall, analysts have given Vertex an average Outperform rating, with price targets ranging from $27 to $45.

JMP Securities’ positive outlook aligns with other analysts who see potential in Vertex. Analyst Patrick Walravens recently gave Vertex a Buy rating with a price target of $42.00.

VERX Stock Analysis: Strong Long-Term Performance but Short-Term Volatility Ahead

On March 2, 2024, VERX stock closed at $33.55, near the top of its 52-week range and above its 200-day simple moving average, indicating strong long-term performance. However, the price decreased by $0.03 or 0.09% since the previous market close, possibly due to various factors such as market conditions, investor sentiment, or company-specific news. In after-hours trading, the stock dropped by $0.34, raising concerns about ongoing selling pressure. Investors should monitor VERX stock closely in the coming days to see if the downward trend continues or if the stock rebounds. Factors like company earnings reports, market conditions, and industry trends can impact the stock’s performance. Despite its long-term strength, recent price drops suggest short-term volatility, so investors should conduct thorough research and consider their risk tolerance before making investment decisions related to VERX stock.

VERX Stock Performance Analysis: Revenue Up, Net Income Mixed on March 2, 2024

On March 2, 2024, VERX stock had mixed performances based on the financial data provided by CNN Money. The total revenue for the company was $572.39 million for the past year, which represented a 16.43% increase compared to the previous year. However, the total revenue for the fourth quarter was $154.91 million, which remained flat compared to the previous quarter.

The net income for VERX was -$13.09 million for the past year, showing a decrease of 6.41% compared to the previous year. However, the net income for the fourth quarter was $15.33 million, which represented a significant increase of 551.13% compared to the previous quarter.

Earnings per share (EPS) for VERX was -$0.09 for the past year, showing a decrease of 4.87% compared to the previous year. The EPS for the fourth quarter was $0.09, which remained flat compared to the previous quarter.

Overall, VERX stock had a mixed performance on March 2, 2024. While the total revenue showed a significant increase compared to the previous year, the net income and earnings per share had mixed results with decreases in the past year but significant increases in the fourth quarter. Investors should closely monitor the company’s financial performance and market trends to make informed decisions regarding VERX stock.

Tags: VERX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Trading online

Challenges and Opportunities The Story of Gritstone Bio

Finance_ Chart Down

Citigroup Analyst Reiterates Sell Rating on Best Buy Co with Increased Price Target

Finances (2)

Analyst Recommendations and Price Targets for Argenx NASDAQ ARGX

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com